Coordinated expression of activated mitogen-activated protein kinases in salivary gland adenoid cystic carcinoma

Human Pathology

Volumn 39, Issue 11, 2008, Pages 1590-1596

  Handra Luca, Adriana ^a   Mauguen, Audrey ^b   Ménard, Philippe ^c,d   Fouret, Pierre ^b,d  

^a HÔPITAL JEAN VERDIER   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

Adenoid cystic carcinoma; Immunohistochemistry; MAPK; Proliferation

Indexed keywords

KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER INVASION; CANCER SURVIVAL; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND CARCINOMA; TUMOR GROWTH;

CARCINOMA, ADENOID CYSTIC; ENZYME ACTIVATION; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RETROSPECTIVE STUDIES; SALIVARY GLAND NEOPLASMS;

EID: 53849099606     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.04.008     Document Type: Article

References (29)

1. Bradley P.J. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 12 (2004) 127-132
2. Chomette G., Auriol M., Tranbaloc P., and Vaillant J.M. Adenoid cystic carcinoma of minor salivary glands. Analysis of 86 cases. Clinico-pathological, histoenzymological and ultrastructural studies. Virchows Arch A Pathol Anat Histol 395 (1982) 289-301
3. Li J., Wang B.Y., Nelson M., et al. Salivary adenocarcinoma, not otherwise specified: a collection of orphans. Arch Pathol Lab Med 128 (2004) 1385-1394
4. Spiro R.H. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8 (1986) 177-184
5. Ellis G.L., and Auclair P.L. Adenoid cystic carcinoma. In: Rosai J., and Sobin L.H. (Eds). Tumors of the salivary glands (1996), Armed Forces Institute of Pathology, Washington (DC) 203-216
6. El-Naggar A.K., and Huvos A.G. Adenoid cystic carcinoma. In: Barnes L., Eveson J., Reichart P., and Sidransky D. (Eds). WHO Classification of Tumours. Pathology and Genetics of Tumours of the Head and Neck (2005), IARC Press, Lyon, France 221-222
7. Szanto P.A., Luna M.A., Tortoledo M.E., and White R.A. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54 (1984) 1062-1069
8. Kokemueller H., Eckardt A., Brachvogel P., and Hausamen J.E. Adenoid cystic carcinoma of the head and neck-a 20 years experience. Int J Oral Maxillofac Surg 33 (2004) 25-31
9. Rapidis A.D., Givalos N., Gakiopoulou H., et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol 41 (2005) 328-335
10. Khafif A, Anavi Y, Haviv J, Fienmesser R, Calderon S, Marshak G. Adenoid cystic carcinoma of the salivary glands: a 20-year review with long-term follow-up. Ear Nose Throat J 2005;84:664-7.
11. Spiro R.H. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174 (1997) 495-498
12. Spiro R.H., and Huvos A. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 164 (1992) 623-628
13. Haddad A., Enepekides D.J., Manolidis S., and Black M. Adenoid cystic carcinoma of the head and neck: a clinicopathologic study of 37 cases. J Otolaryngol 24 (1995) 201-205
14. Chen A.M., Bucci M.K., Weinberg V., et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 66 (2006) 152-159
15. Dodd R.L., and Slevin N.J. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 42 (2006) 759-769
16. Roberts P.J., and Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26 (2007) 3291-3310
17. An J., Sun J.Y., Yuan Q., et al. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol 40 (2004) 400-408
18. Freitas V.M., Vilas-Boas V.F., Pimenta D.C., et al. SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signalling pathway. Am J Pathol 171 (2007) 124-138
19. Zhang C.Y., Mao L., Li L., et al. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. Cancer 110 (2007) 87-95
20. Williams M.D., Chakravarti N., Kies M.S., et al. Implications of methylation patterns of cancer genes in salivary gland tumors. Clin Cancer Res 12 (2006) 7353-7358
21. van der Weyden L., and Adams D.J. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta 1776 (2007) 58-85
22. 2+ pump 4b and the proapoptotic tumor suppressor Ras-associated factor 1 (RASSF1). J Biol Chem 279 (2004) 31318-31328
23. Whang Y.M., Kim Y.H., Kim J.S., and Yoo Y.D. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 65 (2005) 3682-3690
24. Li J., El-Naggar A., and Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 104 (2005) 771-776
25. Al-Haddad S., Zhang Z., Leygue E., et al. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155 (1999) 2057-2066
26. Dhillon A.S., Hagan S., Rath O., and Kolch W. MAP kinase signalling pathways in cancer. Oncogene 26 (2007) 3279-3290
27. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68 (2004) 320-344
28. Ono K., and Han J. The p38 signal transduction pathway: activation and function. Cell Signal 12 (2000) 1-13
29. Kennedy N.J., Cellurale C., and Davis R.J. A radical role for p38 MAPK in tumor initiation. Cancer Cell 11 (2007) 101-103